Cencora, Inc. (COR)

Market Cap	62.03B +3.0%
Revenue (ttm)	332.77B +5.1%
Net Income	2.62B +38.3%
EPS	13.46 +39.1%
Shares Out	190.83M
PE Ratio	24.15
Forward PE	16.86
Dividend	$2.40 (0.74%)
Ex-Dividend Date	Aug 14, 2026

Volume	959,159
Open	325.37
Previous Close	323.85
Day's Range	323.64 - 327.96
52-Week Range	244.82 - 377.54
Beta	0.58
Analysts	Buy
Price Target	369.92 (+13.8%)
Earnings Date	Nov 4, 2026

About COR

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2001
• Employees: 51,000
• Stock Exchange: NYSE
• Ticker Symbol: COR
• Website: https://www.cencora.com

Financial Performance

In fiscal year 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Analyst Summary

According to 14 analysts, the average rating for COR stock is "Buy." The 12-month stock price target is $369.92, which is an increase of 13.80% from the latest price.

Price Target

$369.92

(13.80% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 13, 2026

Data Sources Report a data error